As of 2023, approximately 30% of U.S. adults report symptoms of anxiety and/or depression, a decrease from the peak of 40% in early 2021 but still higher than pre-pandemic levels. Young adults aged 18-29 continue to be disproportionately affected, with nearly 40% reporting anxiety symptoms. Women report higher anxiety rates (36%) compared to men (28%), and those facing household job loss experience significantly higher rates (53%).

 

While anxiety levels have declined since the peak of the pandemic, they remain elevated. The National Institutes of Health (NIH) and the World Health Organization (WHO) note that anxiety and depression rates have increased globally, with a 25% rise during the pandemic.

 

Neurofeedback offers a natural, long-term approach to reducing anxiety by targeting the root cause in the brain, unlike medications that only treat symptoms. By retraining the brain, neurofeedback helps individuals reduce anxiety and improve their quality of life.

Unlike medication, neurofeedback carries few side effects, with the most common being a temporary feeling of tiredness after a session.